The bronchiectasis market report provides current treatment practices, emerging drugs, market share of individual therapies, and current and forecasted 7MM bronchiectasis market size from 2020 to 2034 ...
New research underscores how air pollution and temperature extremes amplify risks for bronchiectasis patients, pointing to critical measures for safeguarding vulnerable groups. Study: Association ...
SINCE Laennec 1 first described and named bronchiectasis its etiology and mode of development have been controversial issues. Numerous theories have been advanced, each of which is backed by ...
Itepekimab is under development for the treatment of chronic obstructive pulmonary disease, non-cystic fibrosis bronchiectasis. It is administered intravenously and subcutaneously. The drug candidate ...
Department of Respiratory and Critical Care Medicine, Xi’an Jiaotong University Second Affiliated Hospital, Xi’an, China Objective: The aim of this study was to conduct a systematic review and ...
BACKGROUND An obstructive defect is usual in bronchiectasis, but the pathophysiological basis of airflow obstruction remains uncertain. High resolution computed tomographic (CT) scanning now allows ...
The NCFB market in the 7 Major Markets was valued at approximately USD 1.45 billion in 2023. Over the forecast period from 2024 to 2034, this market is projected to grow at a CAGR of 14.5%.Dublin, Dec ...
Design Thinking is not an exclusive property of designers—all great innovators in literature, art, music, science, engineering, and business have practiced it. So, why call it Design Thinking? What’s ...